Drugs / ITULAZAX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06085963 Comparator | Feb 2023 → Dec 2024 | seasonal allergic rhinitis | Karolinska Institutet | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ITULAZAX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06085963 ↗ |
| Route | Intranasal | “dissolved ITULAZAX® (1 SQ-Bet/ml) in each nostril” NCT06085963 ↗ |